1,401
Views
3
CrossRef citations to date
0
Altmetric
Original article

Cost-effectiveness of lurasidone vs quetiapine extended-release (XR) in patients with bipolar depression

, , , &
Pages 821-827 | Accepted 14 May 2015, Published online: 27 Jul 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Daisy Ng-Mak, Rachel Halpern, Krithika Rajagopalan & Antony Loebel. (2019) Hospitalization risk in bipolar disorder patients treated with lurasidone versus other atypical antipsychotics. Current Medical Research and Opinion 35:2, pages 211-219.
Read now

Articles from other publishers (2)

Mercedeh Samiei, Zahra Sepehrifar, Reza Daneshmand & Gita Sadighi. (2021) Comparison of Adjunctive Quetiapine Versus Adjunctive Haloperidol in Combination with Sodium Valproate for Treatment of Patients with Mania or Mixed Feature Bipolar I Disorder: A Randomized Double-Blind Clinical Trial Study. Iranian Journal of Psychiatry and Behavioral Sciences 15:2.
Crossref
Ifigeneia Mavranezouli & Joran Lokkerbol. (2016) A Systematic Review and Critical Appraisal of Economic Evaluations of Pharmacological Interventions for People with Bipolar Disorder. PharmacoEconomics 35:3, pages 271-296.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.